Serum Institute's 2nd Covid Vaccine Likely To Be Launched In September

Serum Institute of India, the world's biggest Covid-19 vaccine maker, is hopeful to launch Covovax by September this year, CEO Adar Poonawalla announced on Saturday. ....

 

Full Story

Covid Antiviral Drug Molnupiravir Launched In India

Covid antiviral drug Molnupiravir was on Monday launched in India at Rs 1,399 for a five-day course for mild to moderate infection. ....

 

Full Story

Serum Institute's Covovax Approved For Kids Aged 7 To 11 Years

India's apex drugs regulator, the Drugs Controller General of India (DCGI), on Tuesday approved Pune-based Serum Institute's Covid vaccine Covovax for children aged 7 to 11 years, as per a source. ....

 

Full Story

Govt Panel Recommends Covovax Inclusion In Vaccination Drive For 12 And Above

Covid vaccine Covovax's inclusion in the vaccination programme for the 12-17 years age group has been recommended by the Covid-19 Working Group, official sources said on Sunday. ....

 

Full Story